Santen Announces Health Canada Approval for Cationorm Plus to Relieve the Symptoms of Dry Eye and Ocular Allergy

Santen Canada announced the approval of Cationorm Plus by Health Canada. Cationorm Plus is a hydrating artificial tear that restores moisture in the eye to provide long-lasting relief for dry eye and ocular allergy symptoms.

“Millions of Canadians are impacted by the discomfort and potentially lifestyle-limiting symptoms associated with dry eye and ocular allergy. Artificial tears are considered the first-line treatment to relieve these symptoms,” Craig Wallace, General Manager of Canada, UK, Ireland, and South Africa at Santen, said in a company news release. “We are pleased that with this approval, doctors and patients in Canada will now benefit from the first artificial tear that uses a positive cationic emulsion to provide improved hydration in the eye. The approval of Cationorm Plus is also a significant step forward in our ongoing growth in Canada and throughout North America.”

Cationorm Plus is a sterile, preservative-free, artificial tear containing the novel Novasorb technology. As the only artificial tear that uses positive cationic emulsion to hold hydration in place, Cationorm Plus protects, hydrates, and lubricates the eye while supporting the healing of the cornea. Cationorm Plus is safe for daily use and restores the three layers of the tear film on the eyes to offer relief from eye irritation and discomfort, according to Santen.